QPPV.COM KNOWLEDGE ASSESSMENT

Enzalutamide: Discovery, Development, Safety and Pharmacovigilance

Test your understanding of the concepts covered by Enzalutamide: Discovery, Development, Safety and Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A clinician cites AFFIRM to support enzalutamide use in a patient with metastatic castration-resistant disease who has not received docetaxel. Which evidence limitation is most relevant?
Question 2 of 10 A swallowing-related incident is reported, and the intake record includes only the INN. Why may additional product identification be important?
Question 3 of 10 A company procedure introduces a structured internal workflow for intake, follow-up, signal review and governance. Which statement best distinguishes that procedure from EU legal obligations?
Question 4 of 10 A colleague interprets a hazard ratio of 0.60 as meaning that every treated patient has a 40% probability of avoiding death. Which explanation is most accurate?
Question 5 of 10 What discovery insight most directly motivated the medicinal-chemistry programme that led to enzalutamide?
Question 6 of 10 A patient develops increased toxicity after a strong CYP2C8 inhibitor is added to long-term enzalutamide. Which interaction direction should be considered?
Question 7 of 10 A patient with high-risk biochemical recurrence after local treatment is considered for enzalutamide. Which conclusion best reflects the limits of the evidence and regulatory context?
Question 8 of 10 A patient has difficulty swallowing an enzalutamide tablet. Which response best aligns with the formulation-related safety advice described in the US label?
Question 9 of 10 An evidence summary states that both EMBARK enzalutamide regimens established an overall-survival advantage over leuprolide alone. Which revision is supported by the later analysis?
Question 10 of 10 A reviewer compares radiographic progression-free survival from ARCHES directly with overall survival from AFFIRM and concludes that one regimen is superior because its hazard ratio is lower. What is the main methodological problem?

Select an answer to continue.

QPPV.com